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Abstract
Mosaic Variegated Aneuploidy (MVA) syndrome is a rare autosomal recessive disorder characterized by inaccurate
chromosome segregation and high rates of near-diploid aneuploidy. Children with MVA syndrome die at an early age, are
cancer prone, and have progeroid features like facial dysmorphisms, short stature, and cataracts. The majority of MVA cases
are linked to mutations in BUBR1, a mitotic checkpoint gene required for proper chromosome segregation. Affected
patients either have bi-allelic BUBR1 mutations, with one allele harboring a missense mutation and the other a nonsense
mutation, or mono-allelic BUBR1 mutations combined with allelic variants that yield low amounts of wild-type BubR1
protein. Parents of MVA patients that carry single allele mutations have mild mitotic defects, but whether they are at risk for
any of the pathologies associated with MVA syndrome is unknown. To address this, we engineered a mouse model for the
nonsense mutation 2211insGTTA (referred to as GTTA) found in MVA patients with bi-allelic BUBR1 mutations. Here we
report that both the median and maximum lifespans of the resulting BubR1+/GTTA mice are significantly reduced.
Furthermore, BubR1+/GTTA mice develop several aging-related phenotypes at an accelerated rate, including cataract
formation, lordokyphosis, skeletal muscle wasting, impaired exercise ability, and fat loss. BubR1+/GTTA mice develop mild
aneuploidies and show enhanced growth of carcinogen-induced tumors. Collectively, these data demonstrate that the
BUBR1 GTTA mutation compromises longevity and healthspan, raising the interesting possibility that mono-allelic changes
in BUBR1 might contribute to differences in aging rates in the general population.
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Introduction
Separation of duplicated chromosomes during mitosis is an
intricate biological process whose molecular basis is incompletely
understood. Inaccurate segregation of whole chromosomes results
in numerical chromosome aberrations, referred to as aneuploidy
[1]. Human aneuploidy is intimately associated with developmen-
tal defects and disease pathology [2]. For example, aneuploidy in
gametes is a known cause of infertility, miscarriages and congenital
birth defects [3], while somatic cell aneuploidy is a hallmark of
cancer, with evidence mounting that aneuploidy can promote
neoplastic transformation [4–6]. To safeguard against chromo-
some missegregation, eukaryotic organisms have developed
cellular surveillance systems including the mitotic checkpoint (or
spindle assembly checkpoint) and the attachment error correction
machinery [7]. The mitotic checkpoint is a multi-protein network
that inhibits sister chromatid separation until all chromosomes are
properly attached to the mitotic spindle [8]. One of the core
components of this checkpoint is BubR1, a modular protein that
acts to inhibit the activity of the large multi-protein E3 ubiquitin
ligase known as the anaphase promoting complex/cyclosome
(APC/C), by binding to the co-activating subunit Cdc20 [9]. Once
all chromosomes have achieved bi-orientation, BubR1 dissociates
from Cdc20 leading to the polyubiquitination of securin and cyclin
B1, two inhibitors of separase, a protease that initiates anaphase by
cleaving cohesin rings that physically join duplicated sister
chromosomes together. BubR1 not only promotes accurate
chromosome segregation in its role as a Cdc20 inhibitor, but also
acts to stabilize microtubule-kinetochore attachments [10].
BUBR1 mutations have been identified in various human
malignancies, including gastrointestinal cancers [11–14], and in a
rare human hereditary condition called mosaic variegated
aneuploidy (MVA) syndrome, in which high rates of chromosome
missegregation lead to systemic aneuploidy, typically involving
more than 25% of cells [15,16]. MVA syndrome has clinically
heterogeneic features, including growth deficiency (with prenatal
onset), mental retardation, microcephaly, facial dysmorphisms,
cataracts and other eye abnormalities, short lifespan, and
increased risk for childhood cancers such as rhabdomyosarcoma,
Wilms’ tumor and leukemia [17]. MVA patients with BUBR1
mutations fall into two groups: bi-allelic and mono-allelic
mutations. Patients with bi-allelic mutations carry an allele that
results in premature truncation of BubR1 protein or an absent
transcript, and an allele with a missense mutation often located
within the kinase domain [15]. Patients with mono-allelic
mutations have either a nonsense or missense mutation combined
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with a non-mutated allelic BUBR1 variant that expresses low
amounts of wildtype BubR1 protein [16,17]. BubR1 protein levels
are usually very low in patients with BUBR1 mutations, even in
those with a missense mutation, largely because mutant BubR1
proteins produced by these alleles tend to be quite unstable [18].
Gene knockout studies in mice support the idea of a causal
relationship between BubR1 insufficiency and tumorigenesis.
Although homozygous BubR1 knockouts die as pre-implantation
stage embryos, heterozygous knockouts are viable and show
increased tumor formation when challenged with a carcinogen
[19–21]. BubR1 depletion beyond the level of heterozygous
knockout mice was achieved by the use of knockout (BubR12) and
hypomorphic (BubR1H) alleles [21]. Mice with one hypomorphic
and one knockout allele (BubR12/H mice) express about 4% of
normal BubR1 protein levels and die at birth from respiratory
failure [21]. However, mice with two BubR1 hypomorphic alleles
(BubR1H/H mice) that produce around 10% of normal BubR1
protein levels are viable. Like MVA patients, these mice show
systemic near-diploid aneuploidy, premature chromosome sepa-
ration (PCS) and are susceptible to tumorigenesis [21,22].
However, unlike other mouse models for aneuploidy that have
similar features [1], BubR1H/H mice have a very short lifespan and
develop several progeroid phenotypes at a very young age (within
3 to 5 months), including growth retardation (dwarfism), facial
dysmorphisms, cataracts, muscle wasting, lordokyphosis (rearward
curvature of the spine), fat loss, and cardiac arrhythmias [21,23].
This, together with observations that BubR1 protein levels
decrease during natural aging in various mouse tissues, raises the
possibility that BubR1 is an important regulator of aging [21,24].
MVA syndrome has been documented as a hereditary cancer
syndrome [15–18,25–27], but could potentially be classified also as
a progeroid syndrome based on its phenotypic resemblance to
BubR1 progeroid mice, which includes short lifespan, dwarfism,
facial dysmorphisms, and cataract formation. However, whether
MVA patients have additional age-related phenotypes observed in
BubR1 hypomorphic mice such as fat loss, muscle wasting and
cardiac arrhythmias is a key open question that has been difficult
to address, largely because MVA syndrome is very rare and
because most patient die very young. While patients with the
MVA disorder are rare, heterozygous carriers of BUBR1 mutant
alleles are expected to be much more prevalent in the general
population. If these mutations were to affect healthspan or
longevity, or both, this might provide a genetic basis for why
certain people develop particular age-related traits at faster rates.
Little is known about the health status of parents of MVA patients.
They seem to have a minor mitotic phenotype as evidenced by
their predisposition to PCS, but whether they are at risk for any of
the pathologies associated with MVA syndrome or progeria is
unknown [28–30]. To address this question and to better
understand the relationship between MVA syndrome and
progeria, we engineered mice to carry the human MVA BUBR1
nonsense mutation 2211insGTTA [15]. We demonstrate that
mice harboring this heterozygous BubR1 MVA mutation have a
reduced lifespan and exhibit acceleration of various early age-
related features. In addition, reduced BubR1 protein levels in
BubR1+/GTTA mice results in mild aneuploidy and increases
carcinogen-induced tumor growth. These findings suggest that
mono-allelic BUBR1 mutations might contribute to accelerated
aging and reduced longevity, further supporting the idea that
MVA syndrome is a progeria-like syndrome. Additionally, we
provide important experimental evidence for the longstanding
concept that variations in select genes accelerate the rate of age-
related deterioration of certain tissues and organs.
Results
Generation of a mouse model for MVA BubR1 mutation
2211insGTTA
Human BUBR1 encodes a modular 1052 amino acid serine/
threonine protein kinase that is highly conserved among mamma-
lian species (Figure 1A). Two of the four MVA patients with bi-
allelic BUBR1 mutations reported by Hanks and colleagues [15]
carry a nonsense mutation referred to as 2211insGTTA that results
in a truncated protein that lacks the kinase domain (Figure 1A).
Because of its prevalence, we mimicked this mutation in mice to
understand the potential physiological consequences of MVA
mutations in a heterozygous state. Using homologous recombina-
tion in embryonic stem (ES) cells, we inserted a GTTA sequence in
the murine BubR1 gene at position 2178. This position corresponds
to nucleotide 2211 of the human BUBR1 transcript (Figure 1A and
1B). We injected correctly targeted ES clones into blastocysts and
obtained chimeric mice. These chimeras successfully transmitted
the mutated BubR1 allele (referred to as BubR1NEO;GTTA) to their
offspring (Figure 1B and 1C). BubR1+/NEO;GTTA mice were crossed
to protamine-Cre transgenic mice to remove the NEO gene cassette
(Figure 1B and 1D). BubR1+/GTTA mice were obtained at the
expected frequency and were overtly indistinguishable from control
littermates (data not shown).
Western blot analysis demonstrated that mouse embryonic fibro-
blasts (MEFs) derived from BubR1+/GTTA mice had reduced amounts
of wildtype BubR1 protein (Figure 1E). The level of reduction was
similar to that observed in BubR1+/2MEFs (Figure 1E and Figure S1).
The predicted 730 amino acid truncated protein encoded by the
BubR1GTTA allele was undetectable, even after long exposure times
(Figure 1E), which is consistent with recent observations in cultured
skin fibroblast of anMVA patient carrying the BUBR1GTTA allele [18].
Western blot analysis of testis extracts from BubR1+/GTTA and wildtype
mice confirmed the reduction of BubR1 in cultured MEFs (Figure 1F).
One plausible explanation for the absence of BubR1GTTA encoded
protein on western blots is that nonsense mutations tend to produce
transcripts that are subject to non-sense mediated mRNA decay
[13,16,18]. Alternatively, the truncated protein may be unstable and
subject to rapid proteosomal degradation.
Author Summary
Aging is the main risk factor for the majority of chronic
diseases and the leading cause of death and disability in
humans. Humans age at different rates, but the molecular
genetic basis underlying this phenomenon remains largely
unknown. Efforts to understand how we age have focused
on genetic changes that extend lifespan or underlie
progeroid disorders. One potential progeroid disorder,
MVA syndrome, has been associated with mutations in the
mitotic regulator BUBR1. Although MVA syndrome is rare
due to its recessive nature, individuals carrying heterozy-
gous BUBR1 mutations associated with MVA would be
much more prevalent. However, whether such carriers are
asymptomatic or at risk of developing aspects of MVA
syndrome later in life is unknown. To investigate this, we
engineered mice to carry an analogous mutation to the
human MVA BUBR1 nonsense mutation 2211insGTTA. We
find that these mice have a reduced lifespan and develop
several age-related phenotypes at an accelerated rate.
These findings suggest that bi-allelic integrity of BUBR1 is a
key determinant of healthspan and longevity, and provide
a conceptual framework for elucidating differences in
aging rates among humans.
Reduced Life- and Healthspan in BubR1 MVA Mice
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Figure 1. BubR1+/GTTA mice are viable and mimic their human counterpart. (A) Schematic representation of BubR1 protein. Functional
domains are indicated: KEN, destruction box-motifs implicated in APC/CCdc20 inhibition (also referred to as Cdc20 BD1); TPR, tetratricopeptide motif
for binding to Knl1; GLEBS, motif for Bub3 binding and kinetochore localization; Cdc20 BD2, C-terminal Cdc20 binding domain, Kinase domain,
protein kinase domain homology domain. Red arrowheads indicate human and mouse GTTA insertion sites: the first amino acid of BubR1 impacted
by the insertion is indicated in red font. (B) Gene targeting strategy to generate BubR1+/GTTA mice. Shown are: the genomic mouse BubR1 locus
spanning exon 12 to 21 (top); the targeting vector (TV) with the GTTA insertion in exon 17 (asterisk), loxP sites (blue triangles); the BubR1 locus after
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Patients with MVA syndrome show systemic near-diploid aneu-
ploidies resulting from an inability to separate duplicated chromo-
somes with high accuracy during mitosis [15,16,29]. Although
metaphase spreads from heterozygous carriers of MVA BUBR1
mutations exhibit increased rates of PCS, it is unclear whether parents
of MVA patients are subject to increased aneuploidization
[15,16,26,31–34]. To examine the impact of the BubR1GTTA allele
on chromosome number integrity, we prepared metaphase spreads of
passage 5 BubR1+/GTTA and wildtype MEFs and performed
chromosome counts. Aneuploidy rates of wildtype MEFs were on
average 12% (Figure 1G), which is consistent with rates reported in
previous studies [35–37]. Aneuploidy rates in BubR1+/GTTA MEFs
were significantly increased by 6%, although it should be noted that
this escalation is relatively small compared to that previously observed
in BubR1H/H MEFs [21] (Table S1). Consistent with this, BubR1H/H
MEFs exhibited a more profound reduction in wildtype BubR1
protein levels than BubR1+/GTTA MEFs (Figure 1E and Table S1).
The incidence of PCS was also significantly higher in BubR1+/GTTA
MEFs than in wildtype MEFs (Figure 1G), but again not as high as in
BubR1H/H MEFs [21]. Collectively, these data indicate that the
BubR1GTTA allele that we created in mice faithfully mimics its human
counterpart, and demonstrate that BubR1+/GTTA mice have relatively
mild, but significant, mitotic phenotypes.
Median and maximum lifespans of BubR1+/GTTA mice are
reduced
BubR1H/H mice exhibit various aging-related phenotypes by 3
to 4 months of age [21] (Table S1). BubR1+/GTTA mice, however,
remained overtly indistinguishable from control littermates during
this time period. To examine potential late life phenotypes
associated with the GTTA mutation, we established large cohorts
of BubR1+/GTTA and wildtype mice, which we monitored for signs
of ill health and the development of overt age-related phenotypes.
Kaplan-Meier overall survival curves of these cohorts showed that
the GTTA mutation significantly reduces median and maximum
lifespan, with BubR1+/GTTA mice having a median lifespan of 93
weeks compared to 102 weeks for wildtype mice (Figure 2). By
comparison, BubR1H/H mice had a significantly shortened median
survival of only 30 weeks (Figure 2).
BubR1H/H mice develop quite severe cardiac arrhythmias that are
thought to be the primary cause of premature death of the animals [38]
(Table S1). This prompted us to test whether reduced lifespan of
BubR1+/GTTA mice might be due to cardiac problems. However, the
frequency of cardiac arrhythmias inBubR1+/GTTAmice was not elevated
(Figure S2A). Subsequent cardiac stress tolerance tests, in which a lethal
dose of the b-adrenergic agonist isoproterenol was injected and the time
to death measured [39], further indicated that the cardiac performance
of BubR1+/GTTA mice is not compromised (Figure S2B).
Muscle wasting and cataract formation are accelerated in
BubR1+/GTTA mice
A prominent phenotype of BubR1 hypomorphic mice is
lordokyphosis [21]. The underlying condition here is skeletal
muscle deterioration rather than osteoporosis [23]. BubR1+/GTTA and
wildtype mice in our cohorts were biweekly monitored for this
phenotype. Wildtype mice are known to develop lordokyphosis as part
of their normal aging process [40], a finding commonly attributed to a
combination of muscle wasting and osteoporosis [41,42].Whilemice in
both our cohorts indeed developed lordokyphosis with aging, the
median onset of this age-related phenotype was markedly accelerated
in BubR1+/GTTA mice (89 weeks versus 116 weeks; Figure 3A).
To determine whether this acceleration might be due to early
muscle degeneration, we sacrificed 15-month old BubR1+/GTTA
and wildtype mice and performed muscle fiber diameter
measurements on cross sections of the gastrocnemius, paraspinal
and abdominal muscles. As shown in Figure 3B, average muscle
fiber diameters of BubR1+/GTTA mice were significantly reduced in
all three muscle groups. No such reductions were observed in 3-
month-old BubR1+/GTTA mice (Figure S3). Using qRT-PCR we
analyzed the gastrocnemius of aged BubR1+/GTTA and wildtype
mice for expression of p16Ink4a and p19Arf and found that both
senescence markers were expressed at elevated levels [23,38],
suggesting that senescent cells might contribute to accelerated
muscle degeneration in BubR1+/GTTA mice (Figure 3C). Further-
more, 15-month old BubR1+/GTTA mice had similar bone mineral
densities and contents as wildtype mice as measured by dual
energy x-ray absorptiometry (DEXA; Figure S4), demonstrating
that the early kyphosis is not due to accelerated osteoporosis.
To assess whether early muscle wasting resulted in decreased muscle
function, we performed treadmill exercise tests on BubR1+/GTTA and
wildtype mice at various ages [38,43]. As shown in Figure 3D–3F,
wildtype mice showed similar exercise ability at 3 and 15 months of age.
However, while BubR1+/GTTA mice showed normal exercise ability at 3
months, the duration of exercise, distance travelled and overall amount
of work performed were all significantly decreased at 15 months.
A second early aging-associated phenotype of BubR1 hypomor-
phic mice is cataract formation [21]. MVA patients are also prone
to cataracts, as well as other eye anomalies [16,29]. Our biweekly
inspections of BubR1+/GTTA and wildtype mice revealed that
cataract formation was significantly accelerated in BubR1+/GTTA
mice, with 50% of BubR1+/GTTA mice having cataracts at 101
weeks versus 116 weeks for wildtype mice (Figure 4A). Affected
lenses of both BubR1+/GTTA and wildtype mice had nuclear
cataracts, as revealed by histological evaluation (Figure 4B).
Similar to BubR1H/H lenses [21], BubR1+/GTTA lenses exhibited
posteriorly located epithelial cells (Figure 4B and 4C), although
Morgagnian globules, which are a distinguishing feature of
hypomorphic lenses, were not detected. In contrast, posterior
epithelial cells were rarely observed in wildtype lenses. Taken
together, the above data demonstrate that skeletal muscle
degeneration and cataract formation, two hallmarks of chrono-
logical aging in humans [44], are accelerated in mice carrying the
BubR1 GTTA mutation found in human MVA syndrome.
BubR1 GTTA carriers exhibit early age-related fat loss
In humans, the amount of fat tissue increases during middle age
but then decreases at advanced age [45]. Furthermore, during and
targeted recombination; and the final BubR1+/GTTA locus after protamine-Cre mediated recombination mice to excise the NEO cassette and produce
BubR1+/GTTA mice. The Xmn1 (Xm) and Xho1 (Xh) restriction sites, the Southern blot probe, wildtype and BubR1NEO;GTTA Southern blot fragments, and
the 4 PCR primer sites (a–d) used for genotyping are indicated. (C) Southern blot containing Xmn1/Xho1 digested genomic DNA from two ES cell
clones and probed with DNA fragment indicated in (B) showing the 14 kb and 9 kb fragments representing the wildtype and BubR1NEO;GTTA alleles,
respectively. (D) PCR genotyping of two pups from a BubR1+/NEO:GTTA female crossed to a protamine-Cre male. One pup had the NEO cassette
successfully removed to create a BubR1+/GTTA allele. (E) Western blots of mitotic and asynchronous MEF extracts probed for BubR1, the mitotic marker
p-H3, and actin (loading control). (F) Western blot of testis extracts probed for BubR1. Ponceau S staining was used as loading control. (G) Karyotype
analysis performed on wildtype and BubR1+/GTTA P5 MEFs. Fifty mitotic figures were counted per sample. PCS, premature chromatid separation. An
unpaired t-test was used for statistical analysis. **P,0.01, ***P,0.001.
doi:10.1371/journal.pgen.1003138.g001
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after middle age, fat redistributes from subcutaneous to intra-
abdominal visceral depots. In turn, these deposits shrink in the elderly
as a result of fat redistribution to bonemarrow, muscle, and liver [45].
Previous studies have demonstrated that BubR1H/H progeroid mice
prematurely lose fat from various depots and the subdermal adipose
layer [38,46,47]. To probe for premature changes in fat mass and
redistribution in BubR1+/GTTA mice, we measured the overall
amount of fat (using DEXA scanning on live animals), the mass of
various fat deposits, the subdermal adipose thickness, and the fat cell
size of 15- and 24-month-old BubR1+/GTTA and wildtype males. Body
weight, total fat mass, and weights of major fat depots, including
inguinal adipose tissue (IAT), subscapular adipose tissue (SSAT) and
mesenteric adipose tissue (MES), were all normal in 15-month-old
BubR1+/GTTA mice (Figure 5A–5C). All these values remained
unchanged in 24-month-old wildtype mice. In contrast, however,
body weight, percentage of body fat, and total fat mass of BubR1+/
GTTA were all significantly reduced at 24 months. In addition, several
fat depots shrank significantly, including IAT and brown fat, while
SSAT and MES were trending downward.
Histological analysis showed that the average diameter of fat
cells in IAT of BubR1+/GTTA mice declined significantly between
15 and 24 months (Figure 5D). Fat cell size also decreased in
wildtype mice, but to a lesser extent than in BubR1+/GTTA mice.
Cross sections prepared from lateral skin from 15- and 24-month-
old BubR1+/GTTA and wildtype males revealed a dramatic decline
in subdermal adipose layer thickness with aging selectively in
BubR1+/GTTA males (Figure 5E). In contrast, dermal layer
thickness did not decline (Figure S5).
Loss of fat tissue in BubR1H/H mice is, at least in part, due to
accumulation of senescent cells [38,47]. To determine whether
accelerated fat loss in BubR1+/GTTA mice might involve cellular
senescence, we measured p16Ink4a and p19Arf transcript levels in IAT
of 24-month-old BubR1+/GTTA and wildtype mice by qRT-PCR.
Levels of both senescence markers were markedly increased in
BubR1+/GTTA mice (Figure 5F), indicating that early accumulation of
senescent cells contributes to age-related fat loss in heterozygous
carriers of the BubR1 GTTA mutation found in MVA patients.
BubR1+/GTTA mice develop large carcinogen-induced lung
tumors
MVA patients are prone to tumor formation, including patients
with mono-or bi-allelic BUBR1 mutations [15,16]. Consistent with
this, BubR1H/H mice are highly susceptible to carcinogen-induced
tumors, although it should be noted that spontaneous tumor rates
are not increased [21,23] (Table S1). Similar results have been
reported for mice in which one BubR1 allele has been inactivated
[19]. As a first step to evaluate whether BubR1+/GTTA mice might
be tumor prone we sacrificed BubR1+/GTTA and wildtype mice at
24 months of age and screened internal organs for overt tumors.
This analysis revealed that the incidence of spontaneous tumors
was similar for both genotypes (Figure S6A). Analysis of the tumor
spectra revealed no significant increases in incidence of individual
tumor types (Figure S6B), although there was a trend for increased
tumor multiplicity in BubR1+/GTTA mice.
To complement these studies, we treated BubR1+/GTTA and
wildtype mice with the carcinogen 7,12-dimethylbenz(a)anthra-
cene (DMBA) at postnatal day 5. The mice were then sacrificed at
4 months and analyzed for lung tumor formation. We found that
the tumor incidence and the tumor multiplicity were both very
similar in BubR1+/GTTA and wildtype mice (Figure 6A and 6B).
Interestingly, however, tumor size was dramatically increased in
BubR1+/GTTA mice (Figure 6C). These findings suggest that the
BubR1 GTTA mutation has no obvious impact on tumor initiation
but can promote growth of established tumors.
Mono-allelic loss of BubR1 reduces lifespan
The finding that BubR1+/GTTA and BubR1+/2MEFs have similar
wildtype BubR1 protein levels and the truncated protein encoded
by the GTTA allele is expressed at non-detectable levels raised the
question whether BubR1+/2mice might be phenotypically similar to
BubR1+/GTTA mice. BubR1+/2 MEFs show karyotypic similarity to
BubR1+/GTTA MEFs in that their aneuploidy rates are also modestly
increased [21]. On the other hand, PCS, a hallmark of MVA
patients [15–18,25–27], is elevated in BubR1+/GTTA MEFs but not
in BubR1+/2 MEFs. In an earlier study, in which survival of
BubR1H/H, BubR1+/2, BubR1+/H, and BubR1+/+ mice was analyzed
for up to 15 month of age, yielded no difference in survival between
BubR1+/2 and BubR1+/+ mice [21]. However, a retrospective
analysis of survival records of BubR1+/2 and BubR1+/+ animals that
were maintained until natural death revealed that mono-allelic loss
of BubR1 significantly reduces the median lifespan (90 weeks
compared to 102 weeks for the corresponding BubR1+/+ mice,
Figure 7). There was no statistically significant decrease in
maximum lifespan. We note that these earlier BubR1+/2 and
BubR1+/+ cohorts of mice were not analyzed for any age-related
phenotypes (see Table S1).
Discussion
Biallelic mutations in WRN, CSA and CSB, and DNA repair
genes such as XPB, XPD and TTD are associated with human
diseases that have features of premature aging [48–50]. MVA
syndrome has some progeroid traits, but unlike the above
syndromes has not been widely recognized as a progeroid disorder
[17]. Whether the spectrum of age-related phenotypes of MVA
patients is broader than reported has been difficult to assess,
mainly because MVA patients are very rare and die early [15,16].
It is also unknown whether parents of MVA patients are
susceptible to any of the pathologies associated with MVA
syndrome. We engineered a mouse model to mimic the BubR1
nonsense mutation 2211insGTTA found in MVA patients with bi-
allelic BUBR1 mutations and show that these mice have a
significantly shorter lifespan and develop several age-related
disorders at accelerated rates, including sarcopenia, cataracts,
and loss of fat tissue. These findings strengthen the notion that
MVA syndrome is a progeroid syndrome, and provide important
Figure 2. Lifespan of BubR1+/GTTA is reduced. Kaplan-Meier overall
survival curves. Asterisks denote significance compared to wildtype
mice using a log-rank test: **P,0.01 and ***P,0.001. The maximum
lifespan was significantly decreased in BubR1+/GTTA compared to
wildtype (P=0.0008; two-sided Wang/Allison test referring to the ratio
of mice alive per genotype at the 90th percentile survival point) [70].
doi:10.1371/journal.pgen.1003138.g002
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Figure 3. Accelerated deterioration of skeletal muscle in BubR1+/GTTA mice. (A) Incidence and latency of lordokyphosis. A log rank test was
used for statistical analysis: ***P,0.001. (B) Mean fiber diameter of gastrocnemius (Gastro), abdominal (ABD), and paraspinal muscles of 15-month-old
mice. (C) Expression of the senescence markers p16Ink4a and p19Arf in gastrocnemius muscles of 15 month-old mice analyzed by qRT-PCR. (D–F)
Treadmill exercise ability of 3- and 15-month-old mice: presented are running time (D), distance travelled (E), and workload (F) performed. Error bars
represent SEM. Males mice were used for all analysis in D–F: wildtype 3 months, n = 3 males; BubR1+/GTTA 3 months, n = 5 males, wildtype and BubR1+/
GTTA 15 months, n = 4 males each. An unpaired t-test was used for statistical analyses in (B–F): *P,0.05.
doi:10.1371/journal.pgen.1003138.g003
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experimental evidence for the longstanding concept that variations
in select genes may affect the rate of age-related deterioration in
certain tissues and organs.
To our knowledge, accelerated age-related pathologies have not
been reported in parents of affected individuals with any of the
classical recessive human progeroid syndromes [48–51]. Further-
more, while homozygous knockout or mutant mice have been
established for most of the implicated genes, including WRN, CSA
and CSB, XPB, XPD, and TTD, whether heterozygotes of these
models have reduced longevity or a faster than normal onset of
age-related functional decline in particular tissues has not been
studied in detail [50,52–56]. Thus, based on the findings presented
here, it will not only be important to determine whether
heterozygous MVA BubR1 mutations other than 2211insGTTA
cause age-related phenotypes in mice, but also to perform similar
studies on mice heterozygous for other progeria-associated genes.
Three observations suggest that the phenotypes of BubR1+/GTTA
mice are likely to be caused by reduced expression of wildtype
Figure 4. Cataract formation is accelerated in BubR1+/GTTA mice. (A) Incidence and onset of cataracts in BubR1+/GTTA and wildtype mice. Eyes
were dilated and screened for cataracts using a slit light. A log rank test was used for statistical analysis: *P,0.05. (B) Representative cross sections of
cataractous lenses stained with hematoxylin and eosin. Note that the BubR1+/GTTA lens section contains more posteriorly located (arrowheads). Scale
bars represent 2 mm and 100 mm. (C) Quantitation of posteriorly (P) located epithelial cells in cross sections of cataractous lenses. Error bars represent
SEM. In C we used: n = 10 wildtype and n=9 BubR1+/GTTA 24-month-old animals.
doi:10.1371/journal.pgen.1003138.g004
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Figure 5. Age-related fat loss in BubR1+/GTTA mice. (A) Body fat percentage, lean mass and fat mass of wildtype and BubR1+/GTTA mice measured
by DEXA scanning. (B) Fat depot sizes in wildtype and BubR1+/GTTA mice at the indicated ages. (C) Body weight of wildtype and BubR1+/GTTA mice at
the indicated ages. (D) Average fat cell diameters in IAT of mice at the indicated ages. (E) Average subcutaneous adipose layer thickness of lateral skin
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BubR1 protein without a contribution of truncated BubR1
protein. First, the truncated protein encoded by the GTTA allele
is non-detectable by western blotting, indicating that its level of
expression is very low. Furthermore, residual levels of wildtype
BubR1 protein are similar in BubR1+/GTTA and BubR1+/2 MEFs.
Second, BubR1+/GTTA and BubR1+/2 MEFs have similar aneu-
ploidy rates, suggesting that the extent to which BubR1 is
dysfunctional is the same. Third, BubR1+/GTTA and BubR1+/2
mice show very similar reductions in median lifespan. It will be
important to complement the survival data of BubR1+/2 mice with
a comprehensive analysis of age-related phenotypes, and new
cohorts of BubR1+/2 and BubR1+/+ mice are currently being
established for this purpose.
Previously, we have shown that clearance of p16Ink4a-positive
senescent cells from BubR1H/H mice results in attenuation of
sarcopenia, fat loss, and cataracts, indicating that accumulation of
senescent cells in skeletal muscle, adipose tissue, and eye drives
functional decline in these tissues [38]. This, combined with the
observation that p16Ink4a and p19Arf transcript levels are elevated
in skeletal muscle and fat of BubR1+/GTTA mice suggests that
senescence contributes to the accelerated functional decline in
these animals. On the other hand, accelerated cataractogenesis in
BubR1+/GTTA mice seems to be senescent cell independent (data
not shown). Perhaps, the mere accumulation of epithelial cells in
the posterior portion of the lens is sufficient to accelerate cataract
formation. The main difference between BubR1+/GTTA and
BubR1H/H lenses is that the latter have posteriorly located
Morgagnian globules [21], which may be associated with
senescence and explain why cataractogenesis is much more
accelerated in BubR1H/H than in BubR1+/GTTA mice.
The mechanism by which BubR1 insufficiency induces senes-
cence appears to be more complicated than anticipated
[21,23,57]. It is unlikely that aneuploidy represents the primary
lesion that drives senescence, mainly because other aneuploidy
models with substantially higher aneuploidy rates do not undergo
premature senescence and aging [1,4,6,58]. BubR1 is expressed in
interphase where it apparently continues to serve as an inhibitor of
APC/CCdc20 activity [37]. Consistent with this, recent reports
indicate that APC/CCdc20 E3 ubiquitin ligase activity orchestrates
key developmental processes in post-mitotic neurons, including
dendrite growth and presynaptic differentiation [59,60]. These
findings raise the interesting possibility that BubR1 insufficiency
might lead to unscheduled degradation of APC/CCdc20 substrates
in interphase cells, which, in turn, could lead to cellular stresses
that engage p16Ink4a and induce senescence. Key progeroid
phenotypes of BubR1H/H mice are also observed in BubR1+/GTTA,
but are considerably milder, which correlates with less profound
BubR1 protein insufficiency (Table S1). Various phenotypes seem
unique to BubR1H/H mice including cardiac dysfunction, dwarf-
ism, facial dysmorphisms, and thinning of the dermis, suggesting
that a more extreme level of BubR1 insufficiency is required for
their induction.
BubR1+/GTTA mice are not prone to spontaneous tumors and
show normal tumor incidence and multiplicity when challenged
with the carcinogen DMBA. The most straightforward explana-
tion would be that the level of aneuploidization is insufficient to
promote neoplastic transformation. Consistent with this, Bub3+/2
mice have similarly mild aneuploidy rates as BubR1+/GTTA mice
and are also not prone to spontaneous or DMBA-induced tumors
[61]. However, a significant feature of DBMA-induced lung
tumors of BubR1+/GTTA mice is their large size, indicating that the
mutation promotes tumor aggressiveness without impacting tumor
initiation. It will be interesting to determine whether individuals
carrying the 2211insGTTA mutation are prone to lethal
malignancies.
Our current study and previous data support the notion that
BubR1 protein levels tightly correlate with aneuploidy rates,
cancer susceptibility, lifespan and aging-related phenotypes (Table
S1), indicating that BubR1 is a key determinant of healthspan and
lifespan and warrants a comprehensive analysis of the health status
of the indicated mice. (F) Expression of p16Ink4a and p19Arf in gastrocnemius muscles of 24 month-old mice analyzed by qRT-PCR. For all analyses error
bars represent SEM. For C-F we used: n = 4 15-month-old wildtype and BubR1+/GTTA males; n = 7 24-month-old wildtype males; and n=8 BubR1+/GTTA
24-month-old males. An unpaired t-test was used for statistical analysis in A–F: *P,0.05 and **P,0.01.
doi:10.1371/journal.pgen.1003138.g005
Figure 6. Carcinogen-induced lung tumor size is increased in BubR1+/GTTA mice. (A) Incidence of DMBA-induced lung tumors. (B) Lung
tumor multiplicity. (C) Average lung tumor size. An unpaired t-test was utilized to determine statistical significance: **P,0.01. Color codes in B and C
are as in A. For all analysis error bars represent SEM; n = 19 wildtype and n= 20 BubR1+/GTTA mice.
doi:10.1371/journal.pgen.1003138.g006
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of parents of MVA patients and relatives that are also
heterozygous carriers of the same MVA BUBR1 mutations. In
addition, it would be interesting to screen for BUBR1 mutations in
the general population, either in an unbiased manner or more
selectively in cohorts prone to conditions associated with BubR1
insufficiency in mice, including sarcopenia, cataracts and fat tissue
dysfunction. Subsequent characterization of these mutations, for
instance for impact on BubR1 protein stability, might lead to the
identification of additional BUBR1 variants that influence rates of
age-related deterioration in certain tissues and organs.
Materials and Methods
Generation of BubR1+/GTTA mice
The BubR1GTTA allele was produced by a recombineering based
approach [62]. Briefly, a genomic BubR1 gene fragment of 10 kb
spanning exons 14–19 was retrieved from BAC #bMQ_294E2
(129S7/SvEv ES Cell, Source BioScience) and transferred into
pDTA. Insertion of the GTTA sequence into the exon 17
(c.2178_2179) was done as follows: a tetracyclin-resistance gene
cassette was made by PCR using pKOEZ-40 plasmid as a template
(gift from Dr. Pumin Zhang), the tetra-partite forward primer
(50 bp homology to the target region, GTTA, ClaI, 24 bp homology
to the Tet) 59-CCTGG TGTTCACAGTATCGCCTA-
CAACTGTTAAAATCCCTACTAGAATTAGTTAATCGATG-
GTCGA CGGTATCGATAAGCTTGA-39 and the tri-partite
reverse primer (50 bp homology to the target region, ClaI, 24 bp
homology to the Tet) 59-TCCAGCACAGGCATCGGTC
GGTCTTCCACAGAAAACTCCGCAAAAGCACTATCGATT-
TGGATGGTGAATCC GTTAGCGA-39. The GTTA-ClaI-Tet-
ClaI cassette was inserted into the pDTA-BubR1(E14-E19) by
recombineering. The resulting construct was digested with ClaI and
re-ligated for removal of the Tet gene. Next, a loxP-neomycin
phosphotransferase II (neo) gene-loxP cassette was inserted into the
pDTA-BubR1GTTA (E14-E19) construct, 141 bp upstream of exon
17, using recombineering [62]. The final targeting vector was
linearized withMluI and electroporated into TL1 129Sv/E ES cells.
Transfectants were selected in 350 mg/ml G418 and 0.2 mM FIAU,
and expanded for Southern blot analysis using a 1155 bp 59
external probe on XmnI/XhoI -digested genomic ES cell DNA. The
probe was amplified by PCR from 129Sv/E genomic DNA using
the following primers: 59-GCAGAGTATCCTGACAGGT-
TAAGGCAC-39 and 59-CATAATAATTATCCAACCAT-
GAATGATC-39. Chimeric mice were produced by microinjection
of three independent ES cell targeted clones with 40 chromosomes
into C57BL/6 blastocysts. Chimeric males were mated with
C57BL/6 females and germline transmission of the BubR1-
NEO;GTTA allele was verified by PCR analysis of tail DNA from
pups with a agouti coat color. By crossing BubR1+/NEO;GTTAmice to
protamine-Cre transgenics [63] the NEO cassette was excised. The
following primer combinations were used for PCR genotyping of
mice used in our studies: primers a (59-TCAGATCTCCTA-
GAGCTGGGGTTA-39) and b (59-AATTCTAGTAGGGATTT-
TAA CAGTTG-39) for BubR1GTTA; primers c (59-
GTCTTGTCGATCAGGATGATCTG-39) and d (59-GAAG-
TAGTATTGTTCCTGTGG CAT-39) for BubR1NEO;GTTA. The
targeting vector, targeted ES cells as well as BubR1NEO;GTTA mice
were sequenced for the presence of GTTA insertion by PCR
amplifying the 1.1 kb fragment using primers c and d. Note: in
humans, 2211insGTTA results into S738fsX753 (see Mutation 1,
shared by Family 2 and Family 3 [15]). In mice, 2178–9insGTTA
results in S727fsX750. Insertion of GTTA followed by ClaI coding
sequence, as in our targeting strategy, leads to S727fsX730. All
mice, including BubR1+/2 and BubR1+/+ mice used for survival
analysis, were on a mixed 129 X C57BL/6 genetic background and
housed in a pathogen-free barrier and maintained on a 12 hours
dark/light cycle throughout the study.Mice had ad libitum access to
food containing 10% fat and were inspected daily. Animals used for
survival analysis were mice found dead or sacrificed when
moribund. Mice sacrificed at 15 and 24-months of age were
screened for lymphomas, carcinomas and sarcomas to assess
spontaneous tumorigenesis. Animals sacrificed at 3, 15 and 24-
months for analyses were omitted from survival, lordokyphosis and
cataract incidence curves. All animal protocols were reviewed and
approved by the Mayo Clinic institutional animal care and use
committee.
Generation and culture of MEFs
Wildtype and BubR1+/GTTA MEFs were generated and cultured
as previously described [46]. MEFs were frozen at passage 2 or 3
and used for experimentation at the indicated passages. At least
three wildtype and BubR1+/GTTA lines were used for all
experiments. Mitotic MEFs were generated as previously de-
scribed [36].
Western blotting
Western blot analysis was performed as previously described
[64]. Tissue lysates were prepared by first snap freezing the tissue
in liquid nitrogen upon sacrifice. Frozen tissue was ground into
fine powder with pestle and mortar. 20 mg of tissue powder was
suspended in 200 ml lysis buffer (0.1% NP-40, 10% glycerol in
PBS, plus protease inhibitors) and vortexed for 10 min at 4uC.
After centrifugation at 14000 rpm at 4uC, 150 ml supernatant was
transferred to a 0.5 ml PCR tube and 150 ml Laemmli lysis buffer
was added. The lysate was boiled for 10 min before loading on
Tris-HCl Polyacrylamide gel. Blots were probed with antibodies
for BubR1 (BD), pH3Ser10 (Millipore) and ß-actin (Sigma).
Ponceau S stain was used as a loading control. Quantification of
BubR1 protein levels in BubR1+/GTTA and BubR1+/2 MEF lysates
was done as described [65].
Karyotype analysis
Karyotype analysis on P5 wildtype and BubR1+/GTTA MEFs was
performed as described [66].
Figure 7. Lifespan of BubR1+/2 mice is reduced. Kaplan-Meier
overall survival curves. Asterisks denote significance compared to
wildtype mice using a log-rank test. **P,0.01.
doi:10.1371/journal.pgen.1003138.g007
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Analysis of age-related phenotypes
Bi-weekly monitoring for lordokyphosis and cataract incidence
was performed as described [23]. Fiber diameter measurements were
performed on cross sections of the gastrocnemius and abdominal
muscle from 3 and 15-month-old mice according to previously
described methods [23]. Dissection of the paraspinal muscle was
performed halfway between the front and hind limb, and processed
and measured as the other skeletal muscles. The mean was
calculated from a total of fifty measurements obtained with a
calibrated program (OlympusMicroSuite Five). Measurements of fat
cell diameters were performed according to the same method.
Measurements of the total thickness of dermis and subcutaneous
adipose layer of lateral skin were performed as described [46]. For
histological evaluation of cataracts, whole eyes were paraffin
embedded, sagittally sectioned through the middle of the lens and
stained with hematoxylin and eosin. The number of cells that had
migrated past the epithelial bow of the lens was counted as posterior
localized epithelial cells. DEXA scanning was used to measure bone
mineral density, bone mineral content, percentage of total body fat,
lean mass and fat mass. These measurements were done as described
[67]. Treadmill exercise tests were performed as described [43]. For
isoproterenol stress tests, a lethal dose of isoproterenol (680 mg/kg)
was injected in the chest cavity and time to death was recorded. Mice
were monitored for cardiac arrhythmias using a Vevo2100
ultrasound system (Visualsonics) as described [68].
Quantitative RT–PCR
qRT-PCR analysis on cDNA derived from RNA isolated from
various mouse tissues was as described [23].
Tumor susceptibility
Mice were tested for DMBA induced tumor formation as
previously described [69].
Supporting Information
Figure S1 Quantification of BubR1 protein levels in BubR1+/GTTA
and BubR1+/2MEFs. (A) Western blot analysis of serially diluted
wildtype and representative BubR1+/GTTA and BubR1+/2 MEF
lysates probed for BubR1. Actin was used as a loading control. (B)
The average BubR1 signal intensity of three independent wildtype
MEF lines plotted against percentage of lysate volume loaded using
the equation (Top left). (C) Relative BubR1 protein amount in 3
independent BubR1+/GTTA and BubR1+/2 MEF lines presented as
average 6 SD.
(TIF)
Figure S2 Heart function appears normal in BubR1+/GTTA mice.
(A) Cardiac arrhythmia measurements of wildtype and BubR1+/GTTA
15-month-old male mice shown as percentage of sinus pause
disturbances per heartbeat. BPM, beats per minute. (B) Cardiac
stress tolerance was determined by injection of a lethal dose of
isoproterenol (680 mg/kg) and time to death was recorded. Error
bars represent SEM. For isoproterenol experiments 4 wildtype and 4
BubR1+/GTTA 15-month-old males were used.
(TIF)
Figure S3 BubR1+/GTTA mice show no evidence of sarcopenia at
a young age. Mean fiber diameter measurements on cross sections
of the gastrocnemius (Gastro), abdominal (ABD) and paraspinal
muscle in wildtype and BubR1+/GTTA mice at 3 months of age.
Error bars represent SEM. For all analysis n = 3 wildtype and
n=5 BubR1+/GTTA males.
(TIF)
Figure S4 Bone composition is similar in aged BubR1+/GTTA mice.
Bone composition of 15-month-old wildtype and BubR1+/GTTA mice
as determined by DEXA scanning. BMD, bone mineral density;
BMC, bone mineral content.
(TIF)
Figure S5 Normal age-related decline of dermal thickness in
BubR1+/GTTA mice. Measurements of the average dermal
thickness on cross sections from the lateral skin at the indicated
ages. Error bars represent SEM. n= 4 15-month-old wildtype and
BubR1+/GTTA males; n = 7 24-month-old wildtype mice; and n= 8
BubR1+/GTTA 24-month-old mice.
(TIF)
Figure S6 BubR1+/GTTA mice are not prone to spontaneous
tumors. (A) Spontaneous tumor incidence in 24-month-old wildtype
and BubR1+/GTTA animals. Mice were sacrificed and screened for
lymphomas, carcinomas and sarcomas.(B) Tumor spectrum of 24-
month-old wildtype and BubR1+/GTTA mice. We note that values in
A and B were not statistically different (Fishers’ exact test).
(TIF)
Table S1 Summary of aging-related phenotypes in wildtype,
BubR1+/GTTA, BubR1+/2 and BubR1H/H mice. Aneuploidy rates in
MEFs are indicated as percentage increase over wildtype controls
(wildtype controls for BubR1+/GTTA MEFs had 12% aneuploi-
dy, whereas those of BubR1+/2 and BubR1H/H MEFs had 9%
aneuploidy). ND, not determined. 1 denotes previous published
results [21]; 2 [38]; and 3 [42].
(TIF)
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